[Gradual regulation of osteoclastogenesis mediated by p38 MAP kinase].
Matsumoto
Masahito
M
Saitama Medical University, 38 Moroyama, Iruma, Saitama 350 0495, Japan.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000209:etiology; D002454:Cell Differentiation / Q000235:genetics*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives; D015195:Drug Design; D004791:Enzyme Inhibitors; D005978:Glutathione / Q000031:analogs & derivatives; D006801:Humans; D050778:NFATC Transcription Factors / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology*; D010024:Osteoporosis / Q000209:etiology; D053245:RANK Ligand / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*
D004791:Enzyme Inhibitors; C100496:N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine; D050778:NFATC Transcription Factors; D053245:RANK Ligand; D004295:Dihydroxyphenylalanine; D048051:p38 Mitogen-Activated Protein Kinases; D005978:Glutathione